Clinical trial
Telmisartan Plus Exercise to Improve Functioning in Peripheral Artery Disease
NCT02593110 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Telmisartan Plus Exercise to Improve Functioning in Peripheral Artery Disease
- Lead sponsor
- Northwestern University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 4, 2016
- Completion date
- June 15, 2022
- Enrollment
- 114 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
peripheral artery disease